Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More

Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…

Read More

The Next Phase of Surgical Robotics

Technology advancements like imaging will overlap with changing commercialization models and new hospital realities to enable entirely new patient impacts and economic models.  The post The Next Phase of Surgical Robotics appeared first on MedCity News.

Read More

BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease

Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…

Read More

Maryland Is Training More Health Workers To Offer Abortion Care

In the two counties around nurse practitioner Samantha Marsee’s clinic in rural northeastern Maryland, there’s not a single clinic that provides abortions. And until recently, Marsee herself wasn’t trained to treat patients who wanted to end a pregnancy. “I didn’t really have a lot of knowledge about abortion care,” she said. After Roe v. Wade…

Read More

Living in an Undocumented Immigrant Family Under the Second Trump Administration: Fear, Uncertainty, and Impacts on Health and Well-Being

During his second term, President Trump has implemented an array of immigration policy changes focused on restricting immigration and increasing interior immigration enforcement efforts. These policy changes include restrictions on both lawful and unlawful immigration into the U.S., increased interior enforcement activities to support mass deportation, attempts to end birthright citizenship for the children of…

Read More

More Than Half of the Public Worries Federal Medicaid Budget Cuts Would Affect Their Family’s Ability to Obtain and Afford Care; More Worry It Will Increase the Uninsured 

As Congress weighs spending cuts and other changes to Medicaid, more than half (54%) of the public say they are worried significant reductions in federal Medicaid spending would negatively affect their family’s ability to obtain and afford health care, a new KFF Health Tracking Poll finds. This includes about three in 10 (29%) who say…More

Read More

Poll: Two Thirds Believe Dissolving USAID Will Lead to More Illness and Death Globally, While Nearly Half Say It Would Significantly Reduce the Budget Deficit and Fund Domestic Programs

As the Trump administration works to dissolve the U.S. Agency for International Development (USAID), a new KFF poll finds that two-thirds (67%) of the public believe these actions will increase illness and death in low-income countries, and a similar majority (62%) believe it will result in more humanitarian crises around the world. At the same…More

Read More